![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
12 but Not G
13Departments of Pathology (L.N.S., T.A.F.) and Pharmacology and Cancer Biology (P.J.C.), Duke University Medical Center, Durham, North Carolina
Axin, a negative regulator of the Wnt signaling pathway, contains a canonical regulator of G protein signaling (RGS) core domain. Herein, we demonstrate both in vitro and in cells that this domain interacts with the
subunit of the heterotrimeric G protein G12 but not with the closely related G
13 or with several other heterotrimeric G proteins. Axin preferentially binds the activated form of G
12, a behavior consistent with other RGS proteins. However, unlike other RGS proteins, that of axin (axinRGS) does not affect intrinsic GTP hydrolysis by G
12. Despite its inability to act as a GTPase-activating protein, we demonstrate that in cells, axinRGS can compete for G
12 binding with the RGS domain of p115RhoGEF, a known G12-interacting protein that links G12 signaling to activation of the small G protein Rho. Moreover, ectopic expression of axinRGS specifically inhibits G
12-directed activation of the Rho pathway in MDA-MB 231 breast cancer cells. These findings establish that the RGS domain of axin is able to directly interact with the
subunit of heterotrimeric G protein G12 and provide a unique tool to interdict G
12-mediated signaling processes.
Address correspondence to: Timothy A. Fields, Department of Pathology, Duke University Medical Center, Box 3712, Durham, NC 27710. E-mail: taf1{at}duke.edu.
This article has been cited by other articles:
![]() |
D. Zhu, R. I. Tate, R. Ruediger, T. E. Meigs, and B. M. Denker Domains Necessary for G{alpha}12 Binding and Stimulation of Protein Phosphatase-2A (PP2A): Is G{alpha}12 a Novel Regulatory Subunit of PP2A? Mol. Pharmacol., May 1, 2007; 71(5): 1268 - 1276. [Abstract] [Full Text] [PDF] |
||||